ÜBER DIESE EPISODE

Englisch
Vereinigte Staaten

NOTIZEN ANZEIGEN 🔗

TRANSKRIPT 🔗

VERGANGENE FOLGEN SUCHEN

Vorhandene Folgen von Biohacking Autism with Nadia Elkhatib. durchsuchen.

WEITERE EPISODEN IN DIESEM PODCAST

More than 600 companies are building autism technology, yet most families have never heard of them. This 20-MIN ESSENTIALS edition condenses my conversation with Dan Feshbach, founder of Multiple and co-founder of TeachTown, into the core ideas families need most. Dan and I explore AI for autism,…
A shorter, focused edition of our full John Slattery conversation. Leucovorin, also known as folinic acid, has become one of the most discussed topics in autism research. John Slattery, co-author of the 2018 randomized double-blind placebo-controlled trial of folinic acid in children with autism an…
What does the brain need to build itself, and why does the answer matter for a child with autism and for the aging brain? In this episode of Biohacking Autism, Nadia Elkhatib talks with Dr. Dayan Goodenowe, PhD, neuroscientist, biochemist and founder of Prodrome Sciences, about autism brain develop…
Leucovorin, also known as folinic acid, has become one of the most discussed topics in autism research. John Slattery, co-author of the 2018 randomized double-blind placebo-controlled trial of folinic acid in children with autism and language impairment, joins Nadia Elkhatib to separate the researc…
More than 600 companies are building autism technology, yet most families have never heard of them. What could change if AI, communication tools, sensory technology, and future neurotechnology reached the people who need them? Dan Feshbach, founder of Multiple and co-founder of TeachTown, joins Na…
Rechtliche Hinweise: Der auf dieser Seite eingebettete Podcast und das Bildmaterial stammen von Nadia Elkhatib, das Eigentum seines Eigentümers ist und nicht mit Listen Notes, Inc. verbunden ist oder von diesen unterstützt wird.